JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Metabolic Diseases, Department of Medicine, University of Padova, Padua, Italy", 
          "id": "http://www.grid.ac/institutes/grid.5608.b", 
          "name": [
            "Division of Metabolic Diseases, Department of Medicine, University of Padova, Padua, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fadini", 
        "givenName": "Gian Paolo", 
        "id": "sg:person.01122137075.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122137075.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Diabetes Unit, SSD Diabetologia, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Diabetes Unit, SSD Diabetologia, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Disoteo", 
        "givenName": "Olga", 
        "id": "sg:person.010554524053.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010554524053.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Diabetes Center District 3, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Diabetes Center District 3, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Candido", 
        "givenName": "Riccardo", 
        "id": "sg:person.01026702544.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026702544.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ravenna Diabetes Clinic, Romagna Local Health Authority, Ravenna, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Ravenna Diabetes Clinic, Romagna Local Health Authority, Ravenna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Di Bartolo", 
        "givenName": "Paolo", 
        "id": "sg:person.0706015255.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706015255.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Department of Emergency and Transplants, University of Bari Aldo Moro, Bari, Italy", 
          "id": "http://www.grid.ac/institutes/grid.7644.1", 
          "name": [
            "Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Department of Emergency and Transplants, University of Bari Aldo Moro, Bari, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Laviola", 
        "givenName": "Luigi", 
        "id": "sg:person.01354727540.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354727540.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine and Aging Sciences (DMSI) and Center for Research on Ageing and Translational Medicine (CeSI-Met), University of Chieti, Chieti, Italy", 
          "id": "http://www.grid.ac/institutes/grid.412451.7", 
          "name": [
            "Department of Medicine and Aging Sciences (DMSI) and Center for Research on Ageing and Translational Medicine (CeSI-Met), University of Chieti, Chieti, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Consoli", 
        "givenName": "Agostino", 
        "id": "sg:person.01117461427.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117461427.40"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s12325-018-0868-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111099911", 
          "https://doi.org/10.1007/s12325-018-0868-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-019-00735-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1123468257", 
          "https://doi.org/10.1007/s13300-019-00735-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-019-00725-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1123157757", 
          "https://doi.org/10.1007/s13300-019-00725-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-018-0452-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104347182", 
          "https://doi.org/10.1007/s13300-018-0452-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-015-0142-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048653953", 
          "https://doi.org/10.1007/s13300-015-0142-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-019-0624-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1113668568", 
          "https://doi.org/10.1007/s13300-019-0624-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-019-00715-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1122193928", 
          "https://doi.org/10.1007/s13300-019-00715-x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-02-07", 
    "datePublishedReg": "2021-02-07", 
    "description": "INTRODUCTION: The aim of this study was to elaborate a consensus on treatment intensification strategies in patients with type 2 diabetes failing basal insulin supported oral therapy (BOT). The panel focused on glucagon-like peptide-1 receptor agonists (GLP-1RA) and basal insulin (BI) combinations.\nMETHODS: The authors developed a Delphi questionnaire organized into ten statements and 77 items that focused on: the definition of BOT and BOT failure, intensification strategies, fixed-dose combinations in general and the BI/GLP-1RA fixed combination. The survey was administered in two rounds to a panel of 80 Italian diabetes specialists, who rated their level of agreement with each item on a 5-point Likert scale. Consensus was predefined as >\u200966% of the panel agreeing/disagreeing on any given item.\nRESULTS: Consensus was achieved for 71 of the 77 items. The panel agreed that the use of sulfonylureas in the BOT regimen is inappropriate. BOT failure was defined as individualized targets not being met for glycated hemoglobin, fasting plasma glucose and/or postprandial plasma glucose. There was agreement that postprandial hyperglycaemia and/or presence of nocturnal hypoglycaemia or weight gain define BOT failure. Addition of a GLP-1RA to BI therapy was considered to be the best option for BOT intensification. There was consensus for the use of BI/GLP-1RA fixed combinations as valuable options to increase compliance and safely improve glycaemic control. The panel agreed in considering the fixed-ratio combination insulin degludec/liraglutide (IDegLira) to be preferable to the fixed-ratio combination insulin glargine/lixisenatide (iGlarLixi) in the control of glycaemia, body weight and cardiovascular risk.\nCONCLUSION: According to this Delphi consensus, the addition of a GLP-1RA may be the best option to intensify BOT. The BI/GLP-1RA fixed combinations may increase compliance and optimize the advantages of each of these molecules.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13300-021-01012-2", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1044057", 
        "issn": [
          "1869-6953", 
          "1869-6961"
        ], 
        "name": "Diabetes Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "keywords": [
      "GLP-1RAs", 
      "basal insulin", 
      "plasma glucose", 
      "glucagon-like peptide-1 receptor agonists", 
      "insulin degludec/liraglutide", 
      "insulin glargine/lixisenatide", 
      "peptide-1 receptor agonists", 
      "agonist combination therapy", 
      "postprandial plasma glucose", 
      "use of sulfonylureas", 
      "treatment intensification strategies", 
      "fixed-dose combination", 
      "type 2 diabetes", 
      "control of glycaemia", 
      "treatment intensification", 
      "oral therapy", 
      "insulin combinations", 
      "nocturnal hypoglycaemia", 
      "glycaemic control", 
      "cardiovascular risk", 
      "postprandial hyperglycaemia", 
      "oral treatment", 
      "diabetes specialists", 
      "BI therapy", 
      "combination therapy", 
      "receptor agonist", 
      "glycated hemoglobin", 
      "Delphi consensus", 
      "body weight", 
      "type 2", 
      "level of agreement", 
      "therapy", 
      "valuable option", 
      "insulin", 
      "best option", 
      "Delphi questionnaire", 
      "Likert scale", 
      "failure", 
      "options", 
      "glucose", 
      "lixisenatide", 
      "liraglutide", 
      "hyperglycaemia", 
      "hypoglycaemia", 
      "regimen", 
      "glycaemia", 
      "patients", 
      "diabetes", 
      "consensus", 
      "compliance", 
      "agonists", 
      "sulfonylureas", 
      "hemoglobin", 
      "panel", 
      "treatment", 
      "intensification strategies", 
      "risk", 
      "control", 
      "questionnaire", 
      "subjects", 
      "combination", 
      "items", 
      "aim", 
      "use", 
      "specialists", 
      "target", 
      "addition", 
      "levels", 
      "weight", 
      "strategies", 
      "study", 
      "survey", 
      "presence", 
      "rounds", 
      "scale", 
      "authors", 
      "Delphi", 
      "molecules", 
      "statements", 
      "definition", 
      "intensification", 
      "disagreeing", 
      "advantages", 
      "agreement", 
      "bots", 
      "basal insulin (BI) combinations", 
      "definition of BOT", 
      "BOT failure", 
      "BI/GLP-1RA", 
      "Italian diabetes specialists", 
      "BOT regimen", 
      "weight gain define BOT failure", 
      "gain define BOT failure", 
      "define BOT failure", 
      "BOT intensification", 
      "fixed-ratio combination insulin degludec/liraglutide", 
      "combination insulin degludec/liraglutide", 
      "degludec/liraglutide", 
      "fixed-ratio combination insulin glargine/lixisenatide", 
      "combination insulin glargine/lixisenatide", 
      "glargine/lixisenatide", 
      "GLP-1 Receptor Agonist Combination Therapies", 
      "Receptor Agonist Combination Therapies"
    ], 
    "name": "Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies", 
    "pagination": "781-800", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1135197350"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13300-021-01012-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "33550569"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13300-021-01012-2", 
      "https://app.dimensions.ai/details/publication/pub.1135197350"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_900.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13300-021-01012-2"
  }
]

Download the RDF metadata as:  json-ld nt turtle xml License info

This table displays all metadata directly associated to this object as RDF triples.

241 TRIPLES      22 PREDICATES      136 URIs      121 LITERALS      7 BLANK NODES